首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1378638

桿狀病毒表達系統市場：依產品類型、依應用、依最終用戶、依地區

Baculovirus Expression System Market, By Product Type, By Application, By End User, By Geography

出版日期: 2023年09月28日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

桿狀病毒表達系統市場規模預計將從 2023 年的 3.6849 億美元增加到 2030 年的 6.6075 億美元，預測期內年複合成長率為 8.7%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	3.685 億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	8.70%	2030年市場規模預測	6.607 億美元

圖 1. 桿狀病毒表達系統的全球市場佔有率(%)（依地區），2023 年

桿狀病毒表達系統是生物技術中用於生產重組蛋白的通用且廣泛使用的工具。桿狀病毒是感染昆蟲細胞的昆蟲病毒，經過改造後可表達感興趣的外源基因。與其他表達系統系統相比，此表達系統具有多種優勢，包括高蛋白產量、轉譯後修飾和可擴展性。

桿狀病毒表達系統應用於多個領域，包括生物製藥生產、蛋白質研究、疫苗開發和基因治療。該系統多年來經過廣泛研究和最佳化，並提高了效率和多功能性。

市場動態：

桿狀病毒表達系統市場預計在未來幾年將顯著成長。這種成長是由多種因素推動的，包括用於治療和研究目的的重組蛋白的需求不斷增加。桿狀病毒表達系統由於能夠產生大量複雜的功能性蛋白質而在生物製藥行業中受到青睞。

市場的另一個促進因素是對開發新型治療方法和疫苗的研發活動的投資不斷增加。桿狀病毒表達系統為此類生技藥品的生產提供了可靠且具成本效益的平台。

但市場也存在一定的抑制因素。主要課題之一是使用桿狀病毒表達系統的蛋白質生產過程複雜且耗時。最佳化和擴展系統需要技術專業知識並且非常耗時。

也就是說，市場上存在大量成長機會。對個人化醫療和先進療法開發的日益關注正在創造對客製化蛋白質生產系統的需求。桿狀病毒表達系統以其彈性和產生多種蛋白質的能力，能夠很好地滿足這項需求。

本研究的主要特點

本報告對全球桿狀病毒表達系統市場進行了詳細分析，包括以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率。
本報告還揭示各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
本報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
介紹了全球桿狀病毒表達系統市場的主要參與者，包括公司亮點、產品系列、主要亮點、財務實績和策略。
該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的資訊。
全球桿狀病毒表達系統市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以從用於分析全球桿狀病毒表達系統市場的策略矩陣中受益，這有助於決策。

市場動態
- 促進因素
用於治療和研究目的的重組蛋白需求不斷增加
- 抑制因素
複雜且耗時的蛋白質生產過程
- 機會
對個人化醫療和先進治療方法開發的日益關注
影響分析
主要亮點
監管場景
產品發布/核准
PEST分析
波特的分析
併購場景

第4章桿狀病毒表達系統市場－冠狀病毒（COVID-19）疫情的影響

新型冠狀病毒感染疾病（COVID-19）的流行病學
供需面分析
經濟影響

第5章桿狀病毒表達系統市場，依產品類型，2023-2030

桿狀病毒
表達載體
試劑
其他

第6章桿狀病毒表達系統市場，依應用分類，2023-2030 年

療法
疫苗
蛋白質精製
其他

第7章桿狀病毒表達系統市場，依最終用戶分類，2023-2030 年

生物製藥公司
調查機構
其他

第8章桿狀病毒表達系統市場，依地區，2023-2030

北美洲
歐洲
亞太地區
拉丁美洲
中東和非洲

第9章競爭形勢

Thermo Fisher Scientific
Merck KGaA
Takara Bio（Part of Otsuka Holdings）
Agilent Technologies
Oxford Expression Technologies
Promega Corporation
Qiagen NV
Bio-Rad Laboratories
New England Biolabs
Genscript Biotech Corporation
Syngene International Limited
Sartorius AG（BIA Separations）
Aragen Bioscience
Vivopure
Creative Biogene
Absolute Antibody
Rockland Immunochemicals
Protein Technologies, Inc.（PTI）
Proteogenix
Virovek

第10章章

調查方法
關於出版商

簡介目錄

Product Code: CMI6360

The Baculovirus Expression System Market size is expected to reach US$ 660.75 million by 2030, from US$ 368.49 million in 2023, at a CAGR of 8.7% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 368.5 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	8.70%	2030 Value Projection:	US$ 660.7 Mn

Figure 1. Global Baculovirus Expression System Market Share (%), by Region, 2023

Baculovirus Expression System Market - IMG1

The Baculovirus Expression System is a highly versatile and widely utilized tool in biotechnology for the production of recombinant proteins. Baculoviruses are insect viruses that infect insect cells, and they have been engineered to express foreign genes of interest. This system offers several advantages over other expression systems, including high protein yields, post-translational modifications, and scalability.

The baculovirus expression system has found applications in various fields, such as biopharmaceutical production, protein research, vaccine development, and gene therapy. The system has been extensively studied and optimized over the years, leading to improved efficiency and versatility.

Market Dynamics:

The Baculovirus Expression System market is expected to witness significant growth in the coming years. Several factors are driving this growth, including the increasing demand for recombinant proteins for therapeutic and research purposes. The system's ability to produce high levels of complex and functional proteins has made it a preferred choice in the biopharmaceutical industry.

Another driver of the market is the rising investment in research and development activities for the development of novel therapies and vaccines. The Baculovirus Expression System provides a reliable and cost-effective platform for the production of these biologics.

However, the market also faces certain restraints. One of the major challenges is the complex and time-consuming process of protein production using the Baculovirus Expression System. The optimization and scaling-up of the system require technical expertise and can be labor-intensive.

Nevertheless, the market presents numerous opportunities for growth. The increasing focus on personalized medicine and the development of advanced therapeutics create a demand for customized protein production systems. The Baculovirus Expression System, with its flexibility and ability to produce a wide range of proteins, is well-positioned to meet this demand.

Key Features of the Study:

This report provides in-depth analysis of the global Baculovirus Expression System market, including market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), with 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
Key players in the global Baculovirus Expression System market are profiled, including company highlights, product portfolios, key highlights, financial performance, and strategies.
The key companies covered in this study include Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, and Virovek.
Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics.
The global Baculovirus Expression System market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would benefit from the strategy matrices used in analyzing the global Baculovirus Expression System market, making decision-making easier.

Baculovirus Expression System Market Segmentation:

By Product Type
- Baculovirus
- Expression Vector
- Reagents
- Others
By Application
- Therapeutics
- Vaccines
- Protein Purification
- Others
By End User
- Biopharmaceutical Companies
- Research Institutes
- Others
By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
Top companies in Baculovirus Expression System Market:
- Thermo Fisher Scientific
- Merck KGaA
- Takara Bio (Part of Otsuka Holdings)
- Agilent Technologies
- Oxford Expression Technologies
- Promega Corporation
- Qiagen N.V.
- Bio-Rad Laboratories
- New England Biolabs
- Genscript Biotech Corporation
- Syngene International Limited
- Sartorius AG (BIA Separations)
- Aragen Bioscience
- Vivopure
- Creative Biogene
- Absolute Antibody
- Rockland Immunochemicals
- Protein Technologies, Inc. (PTI)
- Proteogenix
- Virovek

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
The increasing demand for recombinant proteins for therapeutic and research purposes
- Restraints
The complex and time-consuming process of protein production
- Opportunities
The increasing focus on personalized medicine and the development of advanced therapeutics
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Baculovirus Expression System Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Baculovirus Expression System Market , By Product Type, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Baculovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Expression Vector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

6. Baculovirus Expression System Market , By Application, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018- 2030
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Protein Purification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)

7. Baculovirus Expression System Market , By End User, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018- 2030
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)

8. Baculovirus Expression System Market , By Region, 2023-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)

9. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takara Bio (Part of Otsuka Holdings)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Oxford Expression Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
New England Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genscript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Syngene International Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sartorius AG (BIA Separations)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Aragen Bioscience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Vivopure
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Creative Biogene
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Absolute Antibody
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Rockland Immunochemicals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Protein Technologies, Inc. (PTI)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Proteogenix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Virovek
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views